Irofulven in Treating Children With Recurrent or Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

March 31, 2006

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

irofulven

Trial Locations (56)

3052

Royal Children's Hospital, Parkville

6001

Princess Margaret Hospital for Children, Perth

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

10021

Memorial Sloan-Kettering Cancer Center, New York

10032

Columbia Presbyterian Hospital, New York

13210

State University of New York - Upstate Medical University, Syracuse

15213

Children's Hospital of Pittsburgh, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

25704

Veterans Affairs Medical Center - Huntington, Huntington

27710

Duke Comprehensive Cancer Center, Durham

30322

Emory University Hospital - Atlanta, Atlanta

48201

Children's Hospital of Michigan, Detroit

53226

Midwest Children's Cancer Center, Milwaukee

55455

University of Minnesota Cancer Center, Minneapolis

55905

Mayo Clinic Cancer Center, Rochester

60614

Children's Memorial Hospital, Chicago, Chicago

63104

Cardinal Glennon Children's Hospital, St Louis

63110

Washington University School of Medicine, St Louis

64108

Children's Mercy Hospital, Kansas City

72205

University of Arkansas for Medical Sciences, Little Rock

73190

University of Oklahoma Health Sciences Center, Oklahoma City

76104

Cook Children's Medical Center - Fort Worth, Fort Worth

84113

Primary Children's Medical Center, Salt Lake City

91010

City of Hope National Medical Center, Duarte

92868

Children's Hospital of Orange County, Orange

98105

Children's Hospital and Regional Medical Center - Seattle, Seattle

92093-0658

University of California San Diego Cancer Center, La Jolla

90027-0700

Children's Hospital Los Angeles, Los Angeles

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

94143-0128

UCSF Cancer Center and Cancer Research Institute, San Francisco

94305-5408

Stanford University Medical Center, Stanford

20010-2970

Children's National Medical Center, Washington D.C.

32610-0296

University of Florida Health Science Center, Gainesville

60611-3013

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

46202-5289

Indiana University Cancer Center, Indianapolis

66160-7357

University of Kansas Medical Center, Kansas City

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

02111

Boston Floating Hospital Infants and Children, Boston

02115

Dana-Farber Cancer Institute, Boston

48109-0752

University of Michigan Comprehensive Cancer Center, Ann Arbor

39216-4505

University of Mississippi Medical Center, Jackson

07601

Hackensack University Medical Center, Hackensack

08901

Cancer Institute of New Jersey, New Brunswick

14263-0001

Roswell Park Cancer Institute, Buffalo

45229-3039

Children's Hospital Medical Center - Cincinnati, Cincinnati

43205-2696

Children's Hospital of Columbus, Columbus

29425-0721

Medical University of South Carolina, Charleston

37232-6838

Vanderbilt-Ingram Cancer Center, Nashville

75235-9154

Simmons Cancer Center - Dallas, Dallas

77030-2399

Texas Children's Cancer Center, Houston

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

78284-7811

University of Texas Health Science Center at San Antonio, San Antonio

53792-6164

University of Wisconsin Comprehensive Cancer Center, Madison

M5G 1X8

Hospital for Sick Children, Toronto

H3H 1P3

McGill University Health Center - Montreal Children's Hospital, Montreal

H3T 1C5

Hopital Sainte Justine, Montreal

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00003370 - Irofulven in Treating Children With Recurrent or Refractory Solid Tumors | Biotech Hunter | Biotech Hunter